CapitaLand Unveils S$1.4 Billion Geneo Hub, Marking a Chapter for Singapore Science Park

On May 22, 2026, CapitaLand Group (CapitaLand) officially opened Geneo, a life sciences and innovation hub at Singapore Science Park (SSP). The grand opening marks a key milestone in CapitaLand’s multiphase rejuvenation of Singapore’s first research and development (R&D) and technology park. A major highlight of the launch is the landmark announcement that the Agency for Science, Technology and Research (A*STAR) will be establishing dedicated, state-of-the-art biomedical research facilities directly within Geneo.

Jointly owned by CapitaLand Development (CLD) and CapitaLand Ascendas REIT (CLAR), Geneo represents a S$1.4 billion (approximately US$1.09 billion) investment. The hub spans three properties—1, 5, and 7 Science Park Drive—boasting a total gross floor area (GFA) of approximately 180,600 square metres (sqm). This footprint includes roughly 80,000 sqm of purpose-built infrastructure dedicated to biomedical R&D, featuring flexible laboratories and innovation-ready Grade A business park workspaces.

Strategic Investment in Biomedical Leadership

Dr. Tan See Leng, Minister for Manpower and Minister-in-charge of Energy and Science & Technology, presided over the official launch ceremony. In his opening remarks, Dr. Tan emphasized that SSP has been an integral piece of Singapore’s innovation history, having drawn global powerhouses like Illumina, MSD, and Dyson, alongside home-grown champions such as Shopee. He highlighted that Geneo’s S$1.4 billion focus on the biomedical sciences fundamentally positions Singapore as a leading global hub for Research, Innovation, and Enterprise (RIE).

Dr. Tan further noted that due to Singapore’s compact size and resource constraints, the nation cannot rely on scale alone for international standing. Instead, its competitive edge must be forged through technology, innovation, and the creation of high-value-added solutions.

In a headline announcement to the industry, Dr. Tan officially shared that A*STAR will expand its presence in the park by establishing dedicated biomedical research facilities at Geneo. This critical move brings institutional research, clinical communities, and business partners into closer proximity to accelerate innovation. Other attendees at the ceremony included government agency representatives, SSP tenants and key partners of CapitaLand.

Designing a Future-Ready Ecosystem

Jonathan Yap, CEO of CLD, the master developer and park operator of SSP, highlighted that Geneo is a defining milestone in the precinct’s rejuvenation. “For over 40 years, the Park has been a cornerstone of Singapore‘s economic and innovation growth,” he said , noting its role as a foundational home for entities like CrimsonLogic, Qiagen, Merck, and Chugai. 

Yap then elaborated that Geneo is “a vibrant people-centric development that brings together purpose-built workspaces with curated lifestyle and retail offerings” to support the full innovation cycle from research to commercialization. He also highlighted the broader vision of creating more sustainable spaces for SSP communities to integrate live, work, and play, with residential projects like LyndenWoods and lodging facilities such as Citadines Science Park Singapore.

William Tay, CEO and Executive Director of the manager of CLAR, added that the successful redevelopment underscores CLAR’s proactive strategy to enhance portfolio resilience with future-ready assets. “These high-quality properties are seeing strong tenancy demand from world-leading companies in biomedical sciences, R&D and technology sectors, further reinforcing CLAR’s leadership position in Singapore’s life sciences real estate market. With a portfolio of approximately 4.5 million square feet of properties at Singapore Science Park, CLAR is the largest provider of business park and life sciences space within the precinct.”

World-class Tenants Anchor Geneo’s Life Sciences and Innovation Ecosystem

Geneo has attracted an impressive roster of world-class tenants, anchored by the Agency for Science, Technology and Research (A*STAR), alongside Barry Callebaut, Chugai Pharmabody Research, Henkel, and NSG Bio. These tenants span a diverse array of industries, from biotech and advanced manufacturing to food innovation and pharmaceutical R&D. Their presence at Geneo underscores confidence in CapitaLand’s capabilities in best-in-class developments that support a wide range of R&D activities and innovation needs. It also reinforces CapitaLand’s role as an ecosystem curator, connecting Singapore-based researchers, start-up companies and corporates with global partners, investors as well as institutions.

The specialised infrastructure at Geneo includes:

• Advanced Spaces: Wet lab and wet lab-ready floors alongside flexible coworking laboratory space.
• Tailored Specifications: Architectural units built with high floor loading capacities and smart building management systems.
• Collaborative Ecosystems: Communal spaces and active placemaking programmes designed to encourage cross-disciplinary collaborations.

The life sciences and innovation community at Geneo is further enabled by Bridge+ Geneo. It provides premium flexible workspaces and NSG BioSuites, CapitaLand’s first coworking laboratory facility in partnership with NSG Bio. The facility is Southeast Asia’s largest coworking laboratory which spans over 3,200 sqm (nearly 35,000 square feet). Together, they form The Apex, where researchers, start-ups, corporates and investors connect and scale-up.

The Apex complements The Seed, a genomic garden designed in collaboration with SingHealth Duke-NUS Institute of Biodiversity Medicine, and The Canopy, a 3,000 sqm all-weather event plaza. Inspired by the layers of a forest ecosystem, The Seed represents discovery and growth, while The Canopy brings people and communities together. Collectively, these spaces create a holistic environment where science, nature, and community intersect.

Sustainability and Community at the Core

Demonstrating a profound commitment to sustainable development, Geneo achieved the Building and Construction Authority’s (BCA) Green Mark Platinum rating for all three properties, including Super Low Energy for 7 Science Park Drive. Both 1 and 7 Science Park Drive also attained the International WELL Building Institute’s WELL Core Gold Certification for healthy building design. Coupled with SSP’s first distributed district cooling network, energy and water-efficient systems, and smart building technologies, these integrated features help optimize resource efficiency, cater to tenants’ sustainability needs, and reinforce CapitaLand’s long-term commitments.

As part of its corporate social responsibility, SSP in partnership with CapitaLand Hope Foundation and Access Singapore will launch the SSP-ACE! (Access Career Exploration) Programme this year. Through mentorship, workplace engagement, and industry-grounded challenge statements, the Programme offers students from underserved backgrounds meaningful opportunities to explore STEM pathways, while strengthening connections between education, industry and place.

Author

Richard Chau

Related Post

Region

Rakuten Medical Partners with OEP Group to Expand in Asia, Promoting Photoimmunotherapy for Recurrent Head and Neck Cancer

2025-06-26

R&D Frontiers

Singapore’s A*STAR Invests in HoneyBear, Accelerating ARC Cancer Drug Development

2025-03-28

Region

AstraZeneca’s $1.5 Billion ADC Manufacturing Facility in Singapore

2024-05-23